Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

Bladder Cancer, Version 3.2024.

Flaig, Thomas W; Spiess, Philippe E; Abern, Michael; Agarwal, Neeraj; Bangs, Rick; Buyyounouski, Mark K; Chan, Kevin; Chang, Sam S; Chang, Paul; Friedlander, Terence; Greenberg, Richard E; Guru, Khurshid A; Herr, Harry W; Hoffman-Censits, Jean; Kaimakliotis, Hristos; Kishan, Amar U; Kundu, Shilajit; Lele, Subodh M; Mamtani, Ronac; Mian, Omar Y; Michalski, Jeff; Montgomery, Jeffrey S; Parikh, Mamta; Patterson, Anthony; Peyton, Charles; Plimack, Elizabeth R; Preston, Mark A; Richards, Kyle; Sexton, Wade J; Siefker-Radtke, Arlene O; Stewart, Tyler; Sundi, Debasish; Tollefson, Matthew; Tward, Jonathan; Wright, Jonathan L; Cassara, Carly J; Gurski, Lisa A.

J Natl Compr Canc Netw ; 22(4): 216-225, 2024 05.

Artículo en Inglés | MEDLINE | ID: mdl-38754471

2.

BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.

Sun, Steven H; Angell, Colin D; Savardekar, Himanshu; Sundi, Debasish; Abood, David; Benner, Brooke; DiVincenzo, Mallory J; Duggan, Megan; Choueiry, Fouad; Mace, Thomas; Trikha, Prashant; Lapurga, Gabriella; Johnson, Courtney; Carlson, Erick J; Chung, Catherine; Peterson, Blake R; Zhao, Jing; Kendra, Kari L; Carson, William E.

Cancer Immunol Immunother ; 72(11): 3461-3474, 2023 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-37528320

3.

Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.

Wilkins, Lamont J; Tosoian, Jeffrey J; Reichard, Chad A; Sundi, Debasish; Ranasinghe, Weranja; Alam, Ridwan; Schwen, Zeyad; Reddy, Chandana; Allaf, Mohammed; Davis, John W; Chapin, Brian F; Ross, Ashley E; Klein, Eric A; Nyame, Yaw A.

Cancer ; 127(9): 1425-1431, 2021 05 01.

Artículo en Inglés | MEDLINE | ID: mdl-33721334

4.

Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.

Ranasinghe, Weranja; Reichard, Chad A; Nyame, Yaw A; Sundi, Debasish; Tosoian, Jeffrey J; Wilkins, Lamont; Alam, Ridwan; Achim, Mary F; Wang, Xuemei; Stephenson, Andrew J; Klein, Eric A; Ross, Ashley E; Allaf, Mohamad E; Davis, John W; Chapin, Brian F.

J Urol ; 204(4): 748-753, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-32259468

5.

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.

Sundi, Debasish; Tosoian, Jeffrey J; Nyame, Yaw A; Alam, Ridwan; Achim, Mary; Reichard, Chad A; Li, Jianbo; Wilkins, Lamont; Schwen, Zeyad; Han, Misop; Davis, John W; Klein, Eric A; Schaeffer, Edward M; Stephenson, Andrew J; Ross, Ashley E; Chapin, Brian F.

Cancer ; 125(3): 391-397, 2019 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-30423193

6.

Editorial Comment.

Sundi, Debasish.

J Urol ; 211(4): 574, 2024 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-38241206

7.

Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?

Reichard, Chad A; Nyame, Yaw A; Sundi, Debasish; Tosoian, Jeffrey; Wilkins, Lamont; Alam, Ridwan; Achim, Mary F; Wang, Xuemei; Stephenson, Andrew J; Klein, Eric A; Ross, Ashley E; Davis, John W; Chapin, Brian F.

BJU Int ; 124(2): 282-289, 2019 08.

Artículo en Inglés | MEDLINE | ID: mdl-30653804

8.

Editorial Comment.

Ray, Shagnik; Sundi, Debasish.

J Urol ; 208(3): 597, 2022 09.

Artículo en Inglés | MEDLINE | ID: mdl-35892273

9.

Editorial Comment.

Schafer, Johanna M; Sundi, Debasish.

J Urol ; 208(4): 829, 2022 10.

Artículo en Inglés | MEDLINE | ID: mdl-35830560

10.

Risk of Pathological Upgrading and Up Staging among Men with Low Risk Prostate Cancer Varies by Race: Results from the National Cancer Database.

Maurice, Matthew J; Sundi, Debasish; Schaeffer, Edward M; Abouassaly, Robert.

J Urol ; 197(3 Pt 1): 627-631, 2017 03.

Artículo en Inglés | MEDLINE | ID: mdl-27582435

11.

Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience.

Sundi, Debasish; Cohen, Jason E; Cole, Alexander P; Neuman, Brian P; Cooper, John; Faisal, Farzana A; Ross, Ashley E; Schaeffer, Edward M.

Prostate ; 75(2): 191-9, 2015 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-25307625

12.

Identification of men with the highest risk of early disease recurrence after radical prostatectomy.

Sundi, Debasish; Wang, Vinson; Pierorazio, Phillip M; Han, Misop; Partin, Alan W; Tran, Phuoc T; Ross, Ashley E; Bivalacqua, Trinity J.

Prostate ; 74(6): 628-36, 2014 May.

Artículo en Inglés | MEDLINE | ID: mdl-24453066

13.

Editorial Comment.

Sundi, Debasish; Nyame, Yaw A.

J Urol ; 202(2): 254-255, 2019 08.

Artículo en Inglés | MEDLINE | ID: mdl-31107157

14.

Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.

Sundi, Debasish; Kryvenko, Oleksandr N; Carter, H Ballentine; Ross, Ashley E; Epstein, Jonathan I; Schaeffer, Edward M.

J Urol ; 191(1): 60-7, 2014 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-23770146

15.

Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.

Faisal, Farzana A; Sundi, Debasish; Pierorazio, Phillip M; Ball, Mark W; Humphreys, Elizabeth B; Han, Misop; Epstein, Jonathan I; Partin, Alan W; Carter, H Ballentine; Bivalacqua, Trinity J; Schaeffer, Edward M; Ross, Ashley E.

BJU Int ; 114(6b): E120-E129, 2014 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-24731026

16.

Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer.

Verma, Shiv; Swain, Diya; Kushwaha, Prem Prakash; Brahmbhatt, Smit; Gupta, Karishma; Sundi, Debasish; Gupta, Sanjay.

Cancers (Basel) ; 16(2)2024 Jan 05.

Artículo en Inglés | MEDLINE | ID: mdl-38254738

17.

A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines.

Patel, Dixita M; Mateen, Ruba; Qaddour, Noor; Carrillo, Alessandra; Verschraegen, Claire; Yang, Yuanquan; Li, Zihai; Sundi, Debasish; Mortazavi, Amir; Collier, Katharine A.

Cancers (Basel) ; 16(2)2024 Jan 12.

Artículo en Inglés | MEDLINE | ID: mdl-38254823

18.

Roles of Androgen Receptor Signaling in Urothelial Carcinoma.

Sundi, Debasish; Collier, Katharine A; Yang, Yuanquan; Diaz, Dayssy Alexandra; Pohar, Kamal S; Singer, Eric A; Gupta, Sanjay; Carson, William E; Clinton, Steven K; Li, Zihai; Messing, Edward M.

Cancers (Basel) ; 16(4)2024 Feb 10.

Artículo en Inglés | MEDLINE | ID: mdl-38398136

19.

Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.

Purdue, Mark P; Dutta, Diptavo; Machiela, Mitchell J; Gorman, Bryan R; Winter, Timothy; Okuhara, Dayne; Cleland, Sara; Ferreiro-Iglesias, Aida; Scheet, Paul; Liu, Aoxing; Wu, Chao; Antwi, Samuel O; Larkin, James; Zequi, Stênio C; Sun, Maxine; Hikino, Keiko; Hajiran, Ali; Lawson, Keith A; Cárcano, Flavio; Blanchet, Odile; Shuch, Brian; Nepple, Kenneth G; Margue, Gaëlle; Sundi, Debasish; Diver, W Ryan; Folgueira, Maria A A K; van Bokhoven, Adrie; Neffa, Florencia; Brown, Kevin M; Hofmann, Jonathan N; Rhee, Jongeun; Yeager, Meredith; Cole, Nathan R; Hicks, Belynda D; Manning, Michelle R; Hutchinson, Amy A; Rothman, Nathaniel; Huang, Wen-Yi; Linehan, W Marston; Lori, Adriana; Ferragu, Matthieu; Zidane-Marinnes, Merzouka; Serrano, Sérgio V; Magnabosco, Wesley J; Vilas, Ana; Decia, Ricardo; Carusso, Florencia; Graham, Laura S; Anderson, Kyra; Bilen, Mehmet A.

Nat Genet ; 56(5): 809-818, 2024 May.

Artículo en Inglés | MEDLINE | ID: mdl-38671320

20.

Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients' access to novel therapeutics.

Chandra, Michael; Li, Roger; Parwani, Anil; Carson, William E; Pohar, Kamal; Sundi, Debasish.

Urol Oncol ; 41(9): 390.e1-390.e17, 2023 09.

Artículo en Inglés | MEDLINE | ID: mdl-37061453

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Bladder Cancer, Version 3.2024.

BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.

Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.

Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.

Editorial Comment.

Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?

Editorial Comment.

Editorial Comment.

Risk of Pathological Upgrading and Up Staging among Men with Low Risk Prostate Cancer Varies by Race: Results from the National Cancer Database.

Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience.

Identification of men with the highest risk of early disease recurrence after radical prostatectomy.

Editorial Comment.

Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.

Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.

Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer.

A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines.

Roles of Androgen Receptor Signaling in Urothelial Carcinoma.

Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.

Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients' access to novel therapeutics.